RU2021116079A - MODIFIED RHODAMIN DYE AND ITS APPLICATION IN BIOLOGICAL ANALYSIS - Google Patents
MODIFIED RHODAMIN DYE AND ITS APPLICATION IN BIOLOGICAL ANALYSIS Download PDFInfo
- Publication number
- RU2021116079A RU2021116079A RU2021116079A RU2021116079A RU2021116079A RU 2021116079 A RU2021116079 A RU 2021116079A RU 2021116079 A RU2021116079 A RU 2021116079A RU 2021116079 A RU2021116079 A RU 2021116079A RU 2021116079 A RU2021116079 A RU 2021116079A
- Authority
- RU
- Russia
- Prior art keywords
- group
- independently
- oligonucleotide
- reagent
- protected
- Prior art date
Links
- 238000004458 analytical method Methods 0.000 title claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 70
- 229920000272 Oligonucleotide Polymers 0.000 claims 67
- -1 (C7-C20)-arylalkyl Chemical group 0.000 claims 42
- 125000000217 alkyl group Chemical group 0.000 claims 42
- 125000004432 carbon atoms Chemical group C* 0.000 claims 31
- 150000001875 compounds Chemical class 0.000 claims 27
- 229910052757 nitrogen Inorganic materials 0.000 claims 27
- 229910052739 hydrogen Inorganic materials 0.000 claims 26
- 239000001257 hydrogen Substances 0.000 claims 26
- 125000006239 protecting group Chemical group 0.000 claims 24
- 125000005915 C6-C14 aryl group Chemical group 0.000 claims 23
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 22
- 125000006708 (C5-C14) heteroaryl group Chemical group 0.000 claims 21
- 150000002431 hydrogen Chemical class 0.000 claims 21
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 18
- 125000005605 benzo group Chemical group 0.000 claims 12
- 229910052736 halogen Inorganic materials 0.000 claims 11
- 150000002367 halogens Chemical group 0.000 claims 11
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 11
- DTBNBXWJWCWCIK-UHFFFAOYSA-N Phosphoenolpyruvic acid Natural products OC(=O)C(=C)OP(O)(O)=O DTBNBXWJWCWCIK-UHFFFAOYSA-N 0.000 claims 10
- 125000005647 linker group Chemical group 0.000 claims 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 10
- 125000005842 heteroatoms Chemical group 0.000 claims 9
- 229910052760 oxygen Inorganic materials 0.000 claims 9
- 229910052717 sulfur Inorganic materials 0.000 claims 9
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 9
- RWQNBRDOKXIBIV-UHFFFAOYSA-N Thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims 8
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims 8
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 8
- 125000000732 arylene group Chemical group 0.000 claims 8
- 229910052801 chlorine Inorganic materials 0.000 claims 8
- 239000000460 chlorine Substances 0.000 claims 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 8
- 125000005549 heteroarylene group Chemical group 0.000 claims 8
- 239000010452 phosphate Substances 0.000 claims 8
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 claims 8
- 125000002947 alkylene group Chemical group 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 7
- 239000002773 nucleotide Substances 0.000 claims 7
- 125000003729 nucleotide group Chemical group 0.000 claims 7
- 125000004953 trihalomethyl group Chemical group 0.000 claims 7
- 125000004429 atoms Chemical group 0.000 claims 6
- 229910052731 fluorine Inorganic materials 0.000 claims 6
- 239000011737 fluorine Substances 0.000 claims 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims 6
- 125000000524 functional group Chemical group 0.000 claims 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 6
- 125000002950 monocyclic group Chemical group 0.000 claims 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims 6
- 125000005570 polycyclic cycloalkylene group Chemical group 0.000 claims 6
- 230000001681 protective Effects 0.000 claims 6
- LLKYUHGUYSLMPA-UHFFFAOYSA-N Phosphoramidite Chemical group NP([O-])[O-] LLKYUHGUYSLMPA-UHFFFAOYSA-N 0.000 claims 5
- 230000003321 amplification Effects 0.000 claims 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 5
- 125000004076 pyridyl group Chemical group 0.000 claims 5
- LOSIULRWFAEMFL-UHFFFAOYSA-N 7-Deazaguanine Chemical compound O=C1NC(N)=NC2=C1CC=N2 LOSIULRWFAEMFL-UHFFFAOYSA-N 0.000 claims 4
- 229960000643 Adenine Drugs 0.000 claims 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 claims 4
- 229940104302 Cytosine Drugs 0.000 claims 4
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 claims 4
- FDGQSTZJBFJUBT-UHFFFAOYSA-N Hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 claims 4
- 229940090034 Ibu Drugs 0.000 claims 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N Imidazole Chemical compound C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 4
- UGQMRVRMYYASKQ-KMPDEGCQSA-N Inosine Natural products O[C@H]1[C@H](O)[C@@H](CO)O[C@@H]1N1C(N=CNC2=O)=C2N=C1 UGQMRVRMYYASKQ-KMPDEGCQSA-N 0.000 claims 4
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims 4
- 229940113082 Thymine Drugs 0.000 claims 4
- 229940035893 Uracil Drugs 0.000 claims 4
- GJCOSYZMQJWQCA-UHFFFAOYSA-N Xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 229960003786 inosine Drugs 0.000 claims 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 4
- 239000003550 marker Substances 0.000 claims 4
- UFWIBTONFRDIAS-UHFFFAOYSA-N naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 claims 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- RWRDLPDLKQPQOW-UHFFFAOYSA-N pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims 4
- 238000003786 synthesis reaction Methods 0.000 claims 4
- 230000002194 synthesizing Effects 0.000 claims 4
- 125000004417 unsaturated alkyl group Chemical group 0.000 claims 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 3
- 239000003155 DNA primer Substances 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 210000004027 cells Anatomy 0.000 claims 3
- 230000002068 genetic Effects 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 238000002515 oligonucleotide synthesis Methods 0.000 claims 3
- 239000000523 sample Substances 0.000 claims 3
- 238000006467 substitution reaction Methods 0.000 claims 3
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims 2
- 210000004381 Amniotic Fluid Anatomy 0.000 claims 2
- 210000000988 Bone and Bones Anatomy 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- 125000002993 cycloalkylene group Chemical group 0.000 claims 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims 2
- 125000004956 cyclohexylene group Chemical group 0.000 claims 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N furane Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- MNCMBBIFTVWHIP-UHFFFAOYSA-N 1-anthracen-9-yl-2,2,2-trifluoroethanone Chemical group C1=CC=C2C(C(=O)C(F)(F)F)=C(C=CC=C3)C3=CC2=C1 MNCMBBIFTVWHIP-UHFFFAOYSA-N 0.000 claims 1
- 125000002103 4,4'-dimethoxytriphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)(C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H])C1=C([H])C([H])=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims 1
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000001185 Bone Marrow Anatomy 0.000 claims 1
- 210000003756 Cervix Mucus Anatomy 0.000 claims 1
- 210000003608 Feces Anatomy 0.000 claims 1
- 210000002751 Lymph Anatomy 0.000 claims 1
- 210000003296 Saliva Anatomy 0.000 claims 1
- 210000004927 Skin cells Anatomy 0.000 claims 1
- 210000004243 Sweat Anatomy 0.000 claims 1
- 210000002700 Urine Anatomy 0.000 claims 1
- 206010046901 Vaginal discharge Diseases 0.000 claims 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims 1
- 238000001574 biopsy Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000001605 fetal Effects 0.000 claims 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 230000003169 placental Effects 0.000 claims 1
- 239000012521 purified sample Substances 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 239000002689 soil Substances 0.000 claims 1
- 230000003595 spectral Effects 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- 210000001519 tissues Anatomy 0.000 claims 1
- 125000001834 xanthenyl group Chemical group C1=CC=CC=2OC3=CC=CC=C3C(C12)* 0.000 claims 1
Claims (348)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62/782,465 | 2018-12-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2021116079A true RU2021116079A (en) | 2023-01-20 |
RU2809712C2 RU2809712C2 (en) | 2023-12-15 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2787775B2 (en) | Method for synthesizing oligonucleotides labeled with ammonia labile groups on solid support | |
JP2552048B2 (en) | Reagent for nucleotide chain synthesis | |
US5367066A (en) | Oligonucleotides with selectably cleavable and/or abasic sites | |
US5571902A (en) | Synthesis of oligonucleotides | |
US6255476B1 (en) | Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports | |
US6294664B1 (en) | Synthesis of oligonucleotides | |
SK279544B6 (en) | Oligonucleotide analogues with terminal 3'-3' or 5'-5'- -internucleotide linkages, method of their preparation and pharmaceutical compositions them containing | |
WO2011017521A4 (en) | Bicyclic cyclohexose nucleic acid analogs | |
JP7138349B2 (en) | Nucleic acid compounds and oligonucleotides | |
US6870039B2 (en) | Synthesis of oligonucleotides | |
RU2021116079A (en) | MODIFIED RHODAMIN DYE AND ITS APPLICATION IN BIOLOGICAL ANALYSIS | |
JP2022514397A (en) | Modified rhodamine dyes and their use in bioassays | |
AU2019404556A1 (en) | Asymmetric rhodamine dye and use thereof in biological assays | |
JPWO2020132607A5 (en) | ||
AU2006316903B8 (en) | Polynucleotide labelling reagent | |
WO2004018712A1 (en) | OLIGONUCLEOTIDE TAGGED NUCLEOSIDE TRIPHOSPHATES (OTNTPs) FOR GENETIC ANALYSIS | |
WO2020002469A1 (en) | Methods and reagents for cross-linking cellular dna and rna via strain-promoted double-click reactions | |
RU2021116071A (en) | DYE FROM ASYMMETRIC RHODAMINES AND ITS APPLICATION IN BIOLOGICAL ANALYSIS | |
KR100228606B1 (en) | Chemical synthesis of oligonucleotides | |
RU2007110823A (en) | DERIVATIVE OF PHOSPHORAMIDITIS AND METHOD FOR PRODUCING OLIGO-RNA | |
CA2088257A1 (en) | Incorporation of selectably clevable and/or abasic sites into oligonucleotide chains and reagents therefor | |
RU2007126807A (en) | SYNTHESIS OF PHOSPHYTILIZED COMPOUNDS USING A QUARTERLY HETEROCYCLIC ACTIVATOR |